0001062993-24-012192.txt : 20240607
0001062993-24-012192.hdr.sgml : 20240607
20240607162951
ACCESSION NUMBER: 0001062993-24-012192
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saadi Ryan H.
CENTRAL INDEX KEY: 0002011728
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41002
FILM NUMBER: 241029985
MAIL ADDRESS:
STREET 1: C/O TEVOGEN BIO HOLDINGS INC.
STREET 2: 15 INDEPENDENCE BOULEVARD
CITY: WARREN
STATE: NJ
ZIP: 07059
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tevogen Bio Holdings Inc.
CENTRAL INDEX KEY: 0001860871
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981597194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 INDEPENDENCE BOULEVARD, SUITE 410
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 646-807-8832
MAIL ADDRESS:
STREET 1: 15 INDEPENDENCE BOULEVARD, SUITE 410
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Semper Paratus Acquisition Corp
DATE OF NAME CHANGE: 20210505
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-06-05
0001860871
Tevogen Bio Holdings Inc.
TVGN
0002011728
Saadi Ryan H.
C/O TEVOGEN BIO HOLDINGS INC.
15 INDEPENDENCE BLVD, SUITE 410
WARREN
NJ
07059
1
1
1
0
Chief Executive Officer
0
Common Stock
2024-06-05
4
P
0
2607.322
0.7671
A
118252659.322
D
Common Stock
193924
I
By wife
The price reported in Column 4 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7635 to $0.7671, inclusive. The reporting person undertakes to provide to Tevogen Bio Holdings Inc., any security holder of Tevogen Bio Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ Kirti Desai, Attorney-in-Fact
2024-06-07